COP — CompuGroup Medical SE & Co KgaA Cashflow Statement
0.000.00%
Last trade - 00:00- €1.40bn
- €2.11bn
- €1.21bn
Annual cashflow statement for CompuGroup Medical SE & Co KgaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 69 | 74.1 | 46.9 | 34.8 | 28.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -14.2 | 1.41 | 41.2 | -31.9 | 1.27 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.38 | -43.2 | -9.09 | 16 | 11.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 165 | 145 | 180 | 129 | 147 |
| Capital Expenditures | -71.4 | -76.4 | -67.9 | -62.9 | -59.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -92.5 | -69 | -56.5 | -42.4 | -6.45 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -164 | -145 | -124 | -105 | -66.2 |
| Financing Cash Flow Items | -0.179 | -0.192 | -4.54 | -2.72 | -0.309 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 30.2 | -16.4 | -80.7 | 18.8 | -104 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 31.4 | -16.8 | -26.1 | 42.9 | -24.1 |